The US FDA has cleared the first updates to the algorithm of the Omnipod 5 automated insulin delivery (AID) system (Insulet ...

Growth stocks reflect firms on track for swift expansion, beating peers and the overall market. Their strategy to reinvest ...

Second-year receiver Adonai Mitchell, who arrived to the Jets via the Sauce Gardner deadline deal with the Colts last month, ...

Insulet has secured US Food and Drug Administration (FDA) clearance for an algorithm advancement within its Omnipod 5 ...

With an impeccable knowledge of multiple genres and a knack for skilful edits, the Liverpool collective create an unrivalled ...

Insulet (Nasdaq:PODD) announced today that it received FDA 510(k) clearance for new enhancements to its Omnipod 5 system.

December 4, 2025 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the ...

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received FDA 510(k) clearance for ...

Torrey Pines High School. I’ve been living with Type 1 diabetes for over five years, and this weekend, I’ll be attending the ...

Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom (Nasdaq:DXCM) G7 15 ...

Insulet’s stock price target has recently been raised, with the fair value estimate increasing from $366 to $378 following the company's Investor Day and updated outlook. This change reflects ...

Shares of Insulet Corporation (PODD) traded higher on Wednesday after UBS upgraded the insulin pump maker to Buy from Neutral just ahead of its Investor Day on Nov. 20, citing the company’s growth ...